Autism Speaks: The World’s Largest Autism Project Gets Good Press | December 12, 2012 #AutisticHistory #StopBigAutism

#NotAnAutisticAlly EU-AIMS: Autism Research in Europe The World’s Largest Autism Project Gets Good Press  Tuesday, December 18, 2012 Posted by Robert Ring, PhD, Autism Speaks vice president of translational research. I want to point out a recent review article published in the journal Nature Reviews: Drug Discovery. This article provides an excellent introduction to EU-AIMS, a massive five-year research …

Autism Speaks: Unprecedented Academic-Industry Collaboration Seeks New Drugs and Novel Treatments for Autism | March 19, 2012 #AutisticHistory #StopBigAutism

EU-AIMS: Autism Research in Europe Unprecedented Academic-Industry Collaboration Seeks New Drugs and Novel Treatments for Autism Pharmaceutical Companies, Advocacy Organizations, and Universities Join Forces to Discover New Drugs and Assess Novel Treatment Approaches for Autism  (March 19) An international consortium of scientists, led by Roche, King’s College London, and Autism Speaks,  is collaborating on one …

Autism Speaks: Delsia Factsheet (PDF Available) | October 25, 2012 #AutisticHistory #StopBigAutism #BanABA

#NotAnAutisticAlly Autism Speaks: Delsia Fact Sheet (text below). delsia_fact_sheet_102512Download Delsia Fact Sheet Who are we? Delivering Scientific Innovation for Autism (DELSIA) LLC was established as anindependent not-for-profit venture philanthropy affiliate of Autism Speaks. Our vision: To transform outcomes for individuals with autism by ensuring that scientific breakthroughs are developed into products that deliver meaningful improvements …

New Center for Autism and the Developing Brain Breaks Ground in Westchester | April 5, 2012 #AutisticHistory #BanABA #StopBigAutism

Rendering of a group activity room at The Center for Autism and the Developing Brain, a joint initiative of NewYork-Presbyterian and its affiliated medical schools Weill Cornell Medical College and Columbia University College of Physicians and Surgeons, in close collaboration with the New York Center for Autism.Photo credit: daSILVA Architects New Center for Autism and …

Second Genome Presents Preclinical Data Highlighting Potential Therapeutic Implications of Altered Gut Microbiome and Metabolites in Autism Spectrum Disorder Model  … | November 11, 2021 #NotAnAutisticAlly

Second Genome Presents Preclinical Data Highlighting Potential Therapeutic Implications of Altered Gut Microbiome and Metabolites in Autism Spectrum Disorder Model and Parkinson's Disease at The Society for Neuroscience Annual Meeting BRISBANE, Calif., Nov. 11, 2021 /PRNewswire/ -- Second Genome, a biotechnology company that leverages its proprietary platform sg-4sight to discover and develop precision therapies and biomarkers, presented two …

Archived | Autism Speaks Initiatives | Circa 2007 #NotAnAutisticAlly #AutisticHistory

Initiatives  As important as individual grants, initiative projects give Autism Speaks a much more proactive role in promoting specific research. Initiatives frequently involve formation of collaborative research consortia, support of targeted research, organization of research meetings, and creation of research resources. Autism is a complex disease and we believe initiatives that bring together researchers in …

Archived | Autism Speaks: Role of cytokines in developmental neurotoxicity | Circa 2007 #NotAnAutisticAlly

Role of cytokines in developmental neurotoxicity  Ellen Silbergeld, Ph.D., Univeristy of Maryland School of Medicine  Grant Abstract:Methyl mercury (MeHg) is an environmental pollutant that causes profound neurotoxicity and has been associated with autism. (2021 Fact: Vaccines DO NOT CAUSE autism) A major toxic effect associated MeHg exposure in humans is damage to the developing nervous …